Oral disease-modifying therapies for multiple sclerosis: Are we there yet?

Current Neurology and Neuroscience Reports

Volumn 10, Issue 5, 2010, Pages 333-335

  Yadav, Vijayshree ^a   Bourdette, Dennis ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; FINGOLIMOD; PLACEBO;

ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CLINICAL TRIAL; DISABILITY SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER; HUMAN; HYPERTENSION; MULTIPLE SCLEROSIS; NOTE; RETINA MACULA EDEMA; RISK REDUCTION; SIDE EFFECT; SKIN CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77956284747     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0126-2     Document Type: Note

References (5)

1. L Kappos EW Radue P O'Connor, et al. 2010 A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 387 401 10.1056/NEJMoa0909494 1:CAS:528:DC%2BC3cXhvVWltr4%3D 20089952
2. JA Cohen F Barkhof G Comi, et al. 2010 Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N Engl J Med 362 402 415 10.1056/NEJMoa0907839 1:CAS:528:DC%2BC3cXhvVWrsbk%3D 20089954
3. G Giovannoni G Comi S Cook, et al. 2010 A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis N Engl J Med 362 416 426 10.1056/NEJMoa0902533 1:CAS:528:DC%2BC3cXhvVaitr0%3D 20089960
4. J Chun HP Hartung 2010 Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis Clin Neuropharmacol 33 91 101 10.1097/WNF.0b013e3181cbf825 1:CAS:528:DC%2BC3cXksFSgt7g%3D 20061941
5. G Comi P O'Connor X Montalban, et al. 2010 Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results Mult Scler 16 197 207 10.1177/1352458509357065 1:CAS:528:DC%2BC3cXjvFCqu7c%3D 20028707